查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1464918

秋水仙碱市场：按剂型、年龄、给药途径、销售管道、应用 - 全球预测 2024-2030

Colchicine Market by Dosage Formulation (Liquid, Semisolid Gel, Solid), Age (Adult, Children, Senior), Route of Administration, Sales Channels, Application - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年秋水仙碱市场规模为14.6亿美元，预计2024年将达15.8亿美元，2030年将达24.9亿美元，复合年增长率为7.85%。

秋水仙碱是从植物秋水仙（俗称秋番红花）提取的药物。由于它对痛风发作和心膜炎有效，它在医学上占有重要地位。秋水仙碱越来越多使用的主要原因是它具有有效控制和减少与这些疾病相关的发炎并改善患者生活品质的潜力。此外，秋水仙碱的应用已扩展到心血管疾病的治疗，显示出其传统用途之外的潜力。儘管有其好处，秋水仙碱的使用因其狭窄的治疗指数而受到阻碍，如果施用不当，会导致潜在的毒性。减轻此限制需要遵守严格的剂量指南并由医疗保健专业人员进行监测，以确保安全性和有效性。继续探索发炎机制的研究可能会带来新的治疗适应症并扩大在医疗保健领域的应用范围。

主要市场统计
基准年[2023] 14.6亿美元
预测年份 [2024] 15.8亿美元
预测年份 [2030] 24.9亿美元
复合年增长率（%） 7.85%

剂型：秋水仙碱锭剂的易用性、稳定性及普及

液体形式的秋水仙碱在给药方便方面具有优势，特别是对于吞嚥锭剂或锭剂有困难的患者。它还具有剂量弹性，可以根据需要轻鬆调整剂量。液体製剂对儿童和老年患者特别有益。固态凝胶製剂为秋水仙碱的局部给药提供了另一种给药途径。该製剂适合局部治疗，可最大限度地减少与口服秋水仙碱相关的全身性副作用。固态製剂，包括锭剂和胶囊，是秋水仙碱最传统和最广泛使用的剂型。优点是剂量准确、稳定、储存和运输方便。

应用实例提高秋水仙碱治疗痛风的疗效和安全性

光化性角化症是一种皮肤病，其特征是皮肤上出现粗糙的鳞状斑块，主要是由长期阳光照射引起的。虽然传统上不是首选治疗方法，但在某些患者无法耐受其他治疗方法的情况下，可以使用它们。白塞氏症是一种罕见的疾病，会导致全身血管发炎。秋水仙碱很受欢迎，因为它可以减轻口腔溃疡和生殖器溃疡等症状。秋水仙碱被用作疱疹性皮肤炎慢性皮肤病，当对标准Dapsone治疗有抗药性时会引起水痘。遗传性地中海热 (FMF) 是一种遗传性疾病，会导致反覆发烧和发炎。秋水仙碱是 FMF 的主要治疗方法，可预防发作和併发症，包括类淀粉蛋白沉积症。痛风是一种关节炎，会引起突然的剧烈疼痛、肿胀、发红和压痛。佩吉特骨病涉及骨组织的异常破坏和形成。

区域洞察

在美洲，特别是在美国，秋水仙碱的使用受到专利和 FDA核准的严格监管。北美製药巨头正在进行持续的研究和开发，创建了先进但昂贵的医疗保健框架。印度和中国等亚太地区由于拥有大规模的学名药生产能力，对于秋水仙碱的生产极为重要。这些国家注重成本效益的生产，同时努力满足全球标准，并在向世界各地市场供应负担得起的秋水仙碱方面发挥重要作用。由于不同国家的法规环境不同，欧洲、中东和非洲地区呈现多种方法。欧洲国家维持与美洲同样严格的监管标准，强调安全性和有效性，并拥有强大的学名药市场占有率。中东和非洲市场越来越认识到秋水仙碱的重要性，秋水仙碱受到经济差异的影响，并面临获取和负担能力的挑战。

FPNV定位矩阵

FPNV定位矩阵对于评估秋水仙碱市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对秋水仙碱市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告对以下几个方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1. 秋水仙碱市场规模及预测如何？

2.在秋水仙碱市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些？

3. 秋水仙碱市场的技术趋势和法规结构是什么？

4.秋水仙碱市场主要供应商的市场占有率是多少？

5.进入秋水仙碱市场适合的型态和战略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球痛风和心血管疾病盛行率上升
      • 新研究显示秋水仙碱可能有效治疗其他发炎疾病
      • 对心血管疾病管理的需求不断增加
    • 抑制因素
      • FDA核准的製造商数量有限
    • 机会
      • 缓释性或联合治疗的开发
      • 增加研发投资，以提高药物生物有效性、减少副作用并增强病患依从性
    • 任务
      • 确保病患安全和有效性的监管状况
  • 市场区隔分析
    • 剂量配方：秋水仙碱锭剂的易用性、稳定性和广泛可用性
    • 应用：提高秋水仙碱治疗痛风的疗效和安全性
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章 秋水仙碱市场依剂量处方

  • 液体
  • 半固体凝胶
  • 固体的

第七章依年龄分類的秋水仙碱市场

  • 成人用
  • 孩子们
  • 进阶的

第八章秋水仙碱市场：依给药途径

  • 口服
  • 话题

第九章秋水仙碱市场依销售管道

  • 医院药房
  • 网路药房
  • 零售药房

第10章秋水仙碱市场：依应用分类

  • 光化性角化症
  • 白塞氏症
  • 疱疹性皮肤炎
  • 遗传性地中海热
  • 痛风
  • 柏哲氏病

第十一章 美洲秋水仙碱市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太地区秋水仙碱市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲秋水仙碱市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Endo 推出 Mitigare非专利药“秋水仙碱胶囊”
    • Agefa Pharma 的秋水仙碱核准，秋水仙碱是一种治疗心臟病的古老痛风疗法
  • 战略分析和建议

第15章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-351BAD503AE4

[197 Pages Report] The Colchicine Market size was estimated at USD 1.46 billion in 2023 and expected to reach USD 1.58 billion in 2024, at a CAGR 7.85% to reach USD 2.49 billion by 2030.

Colchicine is a medication derived from the plant Colchicum autumnale, commonly known as autumn crocus. It holds a significant place in medical treatment for its efficacy in addressing gout attacks and pericarditis. The expanding use of colchicine is primarily fueled by its potential to manage and reduce the inflammation associated with these conditions effectively, thereby improving patients' quality of life. Furthermore, its application is broadening in cardiovascular disease management, showcasing potential beyond traditional uses. Despite its benefits, colchicine's use is hindered by its narrow therapeutic index, leading to potential toxicity if not dosed properly. This restraint can be mitigated through adherence to strict dosing guidelines and monitoring by healthcare professionals to ensure safety and efficacy. Ongoing research exploring its anti-inflammatory mechanisms may introduce new therapeutic indications, expanding its applicability in the healthcare sector.

KEY MARKET STATISTICS
Base Year [2023] USD 1.46 billion
Estimated Year [2024] USD 1.58 billion
Forecast Year [2030] USD 2.49 billion
CAGR (%) 7.85%

Dosage Formulation: Ease of use, stability, and widespread availability of colchicine tablets

The liquid formulation of colchicine offers advantages in terms of ease of administration, especially for patients who have difficulty swallowing pills or tablets. It allows for dose flexibility, making it easier to adjust doses as required. Liquid formulations are particularly beneficial for pediatric and geriatric patients. The semisolid gel formulation provides an alternative route of administration for colchicine, applied topically. This formulation is preferred for localized treatment, thus minimizing systemic side effects associated with oral colchicine. The solid formulation, encompassing tablets and capsules, is the most traditional and widely used form of colchicine. It offers the benefit of precise dosing, stability, and convenience in terms of storage and transportation.

Application: Improved efficacy and safety of colchicine in gout treatments

Actinic keratosis is a skin condition portrayed by rough, scaly patches on the skin, primarily caused by long-term exposure to the sun. While traditionally not the first line of treatment, colchicine can be used in specific cases where patients cannot tolerate other treatments. Behcet's disease is a rare disorder causing blood vessel inflammation throughout the body. Colchicine is favored for its ability to reduce symptoms such as mouth sores and genital ulcers. Dermatitis herpetiformis, a chronic skin condition that causes blisters, has seen colchicine used as an alternative treatment when patients are resistant to the standard dapsone therapy. Familial mediterranean fever (FMF) is a genetic disorder that causes recurrent fevers and inflammatory conditions. Colchicine is the primary treatment for FMF, preventing attacks and complication, including amyloidosis. Gout is a form of arthritis symptomed sudden, severe episodes of pain, swelling, redness, and tenderness. Paget's disease of bone involves the abnormal breakdown and formation of bone tissue.

Regional Insights

In the Americas, particularly in the United States, colchicine's use is strictly regulated with patents and FDA approval governing its prescription, a scenario that underscores the region's focus on quality and compliance. The major pharmaceutical companies in North America engage in continuous research and development, leading to an advanced but expensive healthcare framework. The APAC region, with countries such as India and China, is pivotal in the production of Colchicine, which is attributed to their large-scale generic pharmaceutical manufacturing capabilities. These countries focus on cost-effective production while striving to meet global standards, playing a crucial role in supplying affordable Colchicine to markets worldwide. The EMEA region showcases a diverse approach due to varying regulatory environments across countries. European nations maintain strict regulatory standards similar to those of the Americas, emphasizing safety and efficacy, coupled with a strong generic market presence. The Middle East and African markets are increasingly recognizing the importance of Colchicine, albeit facing challenges related to access and affordability, influenced by economic disparities.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Colchicine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Colchicine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Colchicine Market, highlighting leading vendors and their innovative profiles. These include AGEPHA Pharma USA, LLC, Alchem International Pvt Ltd, Ascend Laboratories, LLC, Aurobindo Pharma Limited, Bio-Techne Corporation, bioWORLD by GeneLinx International, Inc., Camber Pharmaceuticals, Inc., Dr. Reddy's Laboratories Ltd., Endo International PLC, EURO-PHARM International Canada Inc., Hefei Home Sunshine Pharmaceutical Technology Co., Ltd., Hikma Pharmaceuticals, Indena S.p.A., LGM Pharma, Odan Laboratories Ltd, Pfizer Inc., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., and Vital Laboratories Private Limited.

Market Segmentation & Coverage

This research report categorizes the Colchicine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Dosage Formulation
    • Liquid
    • Semisolid Gel
    • Solid
  • Age
    • Adult
    • Children
    • Senior
  • Route of Administration
    • Oral
    • Topical
  • Sales Channels
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
  • Application
    • Actinic Keratosis
    • Behcet's Disease
    • Dermatitis Herpetiformis
    • Familial Mediterranean Fever
    • Gout
    • Paget's Disease
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Colchicine Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Colchicine Market?

3. What are the technology trends and regulatory frameworks in the Colchicine Market?

4. What is the market share of the leading vendors in the Colchicine Market?

5. Which modes and strategic moves are suitable for entering the Colchicine Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of gout and cardiovascular diseases globally
      • 5.1.1.2. Emerging research suggesting the potential of colchicine in treating other inflammatory diseases
      • 5.1.1.3. Growing need of cardiovascular disease management
    • 5.1.2. Restraints
      • 5.1.2.1. Limited number of FDA-approved manufacturers
    • 5.1.3. Opportunities
      • 5.1.3.1. Developing sustained-release formulations or combination therapies
      • 5.1.3.2. Rising investment in R&D to improving the drug's bioavailability, reducing its side effects, and enhancing patient compliance
    • 5.1.4. Challenges
      • 5.1.4.1. Regulatory landscape ensuring patient safety and efficacy
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Dosage Formulation: Ease of use, stability, and widespread availability of colchicine tablets
    • 5.2.2. Application: Improved efficacy and safety of colchicine in gout treatments
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Colchicine Market, by Dosage Formulation

  • 6.1. Introduction
  • 6.2. Liquid
  • 6.3. Semisolid Gel
  • 6.4. Solid

7. Colchicine Market, by Age

  • 7.1. Introduction
  • 7.2. Adult
  • 7.3. Children
  • 7.4. Senior

8. Colchicine Market, by Route of Administration

  • 8.1. Introduction
  • 8.2. Oral
  • 8.3. Topical

9. Colchicine Market, by Sales Channels

  • 9.1. Introduction
  • 9.2. Hospital Pharmacies
  • 9.3. Online Pharmacies
  • 9.4. Retail Pharmacies

10. Colchicine Market, by Application

  • 10.1. Introduction
  • 10.2. Actinic Keratosis
  • 10.3. Behcet's Disease
  • 10.4. Dermatitis Herpetiformis
  • 10.5. Familial Mediterranean Fever
  • 10.6. Gout
  • 10.7. Paget's Disease

11. Americas Colchicine Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Colchicine Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Colchicine Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Endo Launches Colchicine Capsules, Generic Version of MITIGARE
    • 14.3.2. Agepha Pharma gets ancient gout remedy colchicine across the FDA finish line for heart disease
  • 14.4. Strategy Analysis & Recommendation

15. Competitive Portfolio

  • 15.1. Key Company Profiles
  • 15.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. COLCHICINE MARKET RESEARCH PROCESS
  • FIGURE 2. COLCHICINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL COLCHICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL COLCHICINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL COLCHICINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. COLCHICINE MARKET DYNAMICS
  • FIGURE 7. GLOBAL COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL COLCHICINE MARKET SIZE, BY AGE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL COLCHICINE MARKET SIZE, BY AGE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL COLCHICINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL COLCHICINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS COLCHICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS COLCHICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES COLCHICINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES COLCHICINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. COLCHICINE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 26. COLCHICINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. COLCHICINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL COLCHICINE MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL COLCHICINE MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL COLCHICINE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL COLCHICINE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL COLCHICINE MARKET SIZE, BY LIQUID, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL COLCHICINE MARKET SIZE, BY LIQUID, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL COLCHICINE MARKET SIZE, BY SEMISOLID GEL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL COLCHICINE MARKET SIZE, BY SEMISOLID GEL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL COLCHICINE MARKET SIZE, BY SOLID, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL COLCHICINE MARKET SIZE, BY SOLID, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL COLCHICINE MARKET SIZE, BY ADULT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL COLCHICINE MARKET SIZE, BY ADULT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL COLCHICINE MARKET SIZE, BY CHILDREN, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL COLCHICINE MARKET SIZE, BY CHILDREN, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL COLCHICINE MARKET SIZE, BY SENIOR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL COLCHICINE MARKET SIZE, BY SENIOR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL COLCHICINE MARKET SIZE, BY ORAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL COLCHICINE MARKET SIZE, BY ORAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL COLCHICINE MARKET SIZE, BY TOPICAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL COLCHICINE MARKET SIZE, BY TOPICAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL COLCHICINE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL COLCHICINE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL COLCHICINE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL COLCHICINE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL COLCHICINE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL COLCHICINE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL COLCHICINE MARKET SIZE, BY ACTINIC KERATOSIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL COLCHICINE MARKET SIZE, BY ACTINIC KERATOSIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL COLCHICINE MARKET SIZE, BY BEHCET'S DISEASE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL COLCHICINE MARKET SIZE, BY BEHCET'S DISEASE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL COLCHICINE MARKET SIZE, BY DERMATITIS HERPETIFORMIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL COLCHICINE MARKET SIZE, BY DERMATITIS HERPETIFORMIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL COLCHICINE MARKET SIZE, BY FAMILIAL MEDITERRANEAN FEVER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL COLCHICINE MARKET SIZE, BY FAMILIAL MEDITERRANEAN FEVER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL COLCHICINE MARKET SIZE, BY GOUT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL COLCHICINE MARKET SIZE, BY GOUT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL COLCHICINE MARKET SIZE, BY PAGET'S DISEASE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL COLCHICINE MARKET SIZE, BY PAGET'S DISEASE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS COLCHICINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS COLCHICINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 63. ARGENTINA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 64. ARGENTINA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 65. ARGENTINA COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 66. ARGENTINA COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 67. ARGENTINA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 68. ARGENTINA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 69. ARGENTINA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 70. ARGENTINA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 71. ARGENTINA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 72. ARGENTINA COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 73. BRAZIL COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 74. BRAZIL COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 75. BRAZIL COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 76. BRAZIL COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 77. BRAZIL COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 78. BRAZIL COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 79. BRAZIL COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 80. BRAZIL COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 81. BRAZIL COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 82. BRAZIL COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 83. CANADA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 84. CANADA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 85. CANADA COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 86. CANADA COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 87. CANADA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 88. CANADA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 89. CANADA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 90. CANADA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 91. CANADA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 92. CANADA COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 93. MEXICO COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 94. MEXICO COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 95. MEXICO COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 96. MEXICO COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 97. MEXICO COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 98. MEXICO COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 99. MEXICO COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 100. MEXICO COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 101. MEXICO COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 102. MEXICO COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 103. UNITED STATES COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 104. UNITED STATES COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 105. UNITED STATES COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 106. UNITED STATES COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 107. UNITED STATES COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 108. UNITED STATES COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 109. UNITED STATES COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 110. UNITED STATES COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 111. UNITED STATES COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 112. UNITED STATES COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 113. UNITED STATES COLCHICINE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 114. UNITED STATES COLCHICINE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 128. AUSTRALIA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 130. AUSTRALIA COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 131. AUSTRALIA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 132. AUSTRALIA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 133. AUSTRALIA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 134. AUSTRALIA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 135. AUSTRALIA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 136. AUSTRALIA COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 137. CHINA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 138. CHINA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 139. CHINA COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 140. CHINA COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 141. CHINA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 142. CHINA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 143. CHINA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 144. CHINA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 145. CHINA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 146. CHINA COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 147. INDIA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 148. INDIA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 149. INDIA COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 150. INDIA COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 151. INDIA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 152. INDIA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 153. INDIA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 154. INDIA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 155. INDIA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 156. INDIA COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 157. INDONESIA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 158. INDONESIA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 159. INDONESIA COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 160. INDONESIA COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 161. INDONESIA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 162. INDONESIA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 163. INDONESIA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 164. INDONESIA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 165. INDONESIA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 166. INDONESIA COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 167. JAPAN COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 168. JAPAN COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 169. JAPAN COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 170. JAPAN COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 171. JAPAN COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 172. JAPAN COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 173. JAPAN COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 174. JAPAN COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 175. JAPAN COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 176. JAPAN COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 177. MALAYSIA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 178. MALAYSIA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 179. MALAYSIA COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 180. MALAYSIA COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 181. MALAYSIA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 182. MALAYSIA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 183. MALAYSIA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 184. MALAYSIA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 185. MALAYSIA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 186. MALAYSIA COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 187. PHILIPPINES COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 188. PHILIPPINES COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 189. PHILIPPINES COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 190. PHILIPPINES COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 191. PHILIPPINES COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 192. PHILIPPINES COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 193. PHILIPPINES COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 194. PHILIPPINES COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 195. PHILIPPINES COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 196. PHILIPPINES COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 197. SINGAPORE COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 198. SINGAPORE COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 199. SINGAPORE COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 200. SINGAPORE COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 201. SINGAPORE COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 202. SINGAPORE COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 203. SINGAPORE COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 204. SINGAPORE COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 205. SINGAPORE COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 206. SINGAPORE COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 207. SOUTH KOREA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 208. SOUTH KOREA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 209. SOUTH KOREA COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 210. SOUTH KOREA COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 211. SOUTH KOREA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 212. SOUTH KOREA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 213. SOUTH KOREA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 214. SOUTH KOREA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 215. SOUTH KOREA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 216. SOUTH KOREA COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 217. TAIWAN COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 218. TAIWAN COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 219. TAIWAN COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 220. TAIWAN COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 221. TAIWAN COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 222. TAIWAN COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 223. TAIWAN COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 224. TAIWAN COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 225. TAIWAN COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 226. TAIWAN COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 227. THAILAND COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 228. THAILAND COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 229. THAILAND COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 230. THAILAND COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 231. THAILAND COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 232. THAILAND COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 233. THAILAND COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 234. THAILAND COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 235. THAILAND COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 236. THAILAND COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 237. VIETNAM COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 238. VIETNAM COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 239. VIETNAM COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 240. VIETNAM COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 241. VIETNAM COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 242. VIETNAM COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 243. VIETNAM COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 244. VIETNAM COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 245. VIETNAM COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 246. VIETNAM COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 259. DENMARK COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 260. DENMARK COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 261. DENMARK COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 262. DENMARK COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 263. DENMARK COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 264. DENMARK COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 265. DENMARK COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 266. DENMARK COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 267. DENMARK COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 268. DENMARK COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 269. EGYPT COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 270. EGYPT COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 271. EGYPT COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 272. EGYPT COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 273. EGYPT COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 274. EGYPT COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 275. EGYPT COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 276. EGYPT COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 277. EGYPT COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 278. EGYPT COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 279. FINLAND COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 280. FINLAND COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 281. FINLAND COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 282. FINLAND COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 283. FINLAND COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 284. FINLAND COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 285. FINLAND COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 286. FINLAND COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 287. FINLAND COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 288. FINLAND COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 289. FRANCE COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 290. FRANCE COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 291. FRANCE COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 292. FRANCE COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 293. FRANCE COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 294. FRANCE COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 295. FRANCE COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 296. FRANCE COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 297. FRANCE COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 298. FRANCE COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 299. GERMANY COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 300. GERMANY COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 301. GERMANY COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 302. GERMANY COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 303. GERMANY COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 304. GERMANY COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 305. GERMANY COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 306. GERMANY COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 307. GERMANY COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 308. GERMANY COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 309. ISRAEL COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 310. ISRAEL COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 311. ISRAEL COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 312. ISRAEL COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 313. ISRAEL COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 314. ISRAEL COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 315. ISRAEL COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 316. ISRAEL COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 317. ISRAEL COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 318. ISRAEL COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 319. ITALY COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 320. ITALY COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 321. ITALY COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 322. ITALY COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 323. ITALY COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 324. ITALY COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 325. ITALY COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 326. ITALY COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 327. ITALY COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 328. ITALY COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 329. NETHERLANDS COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 330. NETHERLANDS COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 331. NETHERLANDS COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 332. NETHERLANDS COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 333. NETHERLANDS COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 334. NETHERLANDS COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 335. NETHERLANDS COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 336. NETHERLANDS COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 337. NETHERLANDS COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 338. NETHERLANDS COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 339. NIGERIA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 340. NIGERIA COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 341. NIGERIA COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 342. NIGERIA COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 343. NIGERIA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 344. NIGERIA COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 345. NIGERIA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 346. NIGERIA COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 347. NIGERIA COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 348. NIGERIA COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 349. NORWAY COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 350. NORWAY COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 351. NORWAY COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 352. NORWAY COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 353. NORWAY COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 354. NORWAY COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 355. NORWAY COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 356. NORWAY COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 357. NORWAY COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 358. NORWAY COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 359. POLAND COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 360. POLAND COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 361. POLAND COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 362. POLAND COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 363. POLAND COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 364. POLAND COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 365. POLAND COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 366. POLAND COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 367. POLAND COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 368. POLAND COLCHICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 369. QATAR COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 370. QATAR COLCHICINE MARKET SIZE, BY DOSAGE FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 371. QATAR COLCHICINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
  • TABLE 372. QATAR COLCHICINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
  • TABLE 373. QATAR COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 374. QATAR COLCHICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 375. QATAR COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2018-2023 (USD MILLION)
  • TABLE 376. QATAR COLCHICINE MARKET SIZE, BY SALES CHANNELS, 2024-2030 (USD MILLION)
  • TABLE 377. QATAR COLCHICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)